GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
2,680.00
-30.00 (-1.11%)
Nov 11, 2026, 1:05 PM IST
NSE:GLAXO Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, NSE:GLAXO stock has a consensus rating of "Buy" and an average price target of ₹3,054. The average 1-year stock price forecast is 13.94% higher than the current stock price, while the lowest is ₹2,760 (+2.99%) and the highest is ₹3,500 (+30.60%).
Price Target: ₹3,054 (+13.94%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:GLAXO stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
42.68B
from 38.22B
Increased by 11.68%
Revenue Next Year
47.34B
from 42.68B
Increased by 10.91%
EPS This Year
70.80
from 60.11
Increased by 17.78%
EPS Next Year
79.18
from 70.80
Increased by 11.83%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.